Vimarsana
Biggest News Aggregation in the World

Page 4 - Conversion Labs Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Conversion Labs Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Conversion Labs Inc Today - Breaking & Trending Today

Conversion Labs to Present at the BTIG Virtual MedTech, Digital Health, Life Science & ... - Vimarsana News

Conversion Labs to Present at the BTIG Virtual MedTech, Digital Health, Life Science & ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Conversion Labs to Present at the BTIG Virtual MedTech, Digital Health, Life Science & ... Conversion Labs, Inc.February 17, 2021 GMT NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc.  (NASDAQ: CVLB), a leading direct-to-patient telehealth company, has been invited to present at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held on February 17-19, 2021. ADVERTISEMENT Conversion Labs CEO Justin Schreiber is scheduled to present in a fires...

Source: apnews.com
Unique Logistics International Reports Second Quarter Fiscal 2021 Earnings (Quarter ending November 30, 2020 and the six months ending November 30, 2020) - Vimarsana News

Unique Logistics International Reports Second Quarter Fiscal 2021 Earnings (Quarter ending November 30, 2020 and the six months ending November 30, 2020)

Unique Logistics International Reports Second Quarter Fiscal 2021 Earnings (Quarter ending November 30, 2020 and the six months ending November 30, 2020) News provided by Share this article Share this article NEW YORK, Feb. 8, 2021 /PRNewswire/ -- Unique Logistics International, Inc. (formerly Innocap, Inc.) a global logistics and freight forwarding company, today announced the filing of its Current Report on Form 10-Q (the "Current Report") which included financial results for the three month and six-month period ending November 30, 2020. Key Financial Results: Pro-forma Loss from operati...

Executive Hires: Walgreens Appoints New CEO, Cityblock Health, Innovaccer, Others - Vimarsana News

Executive Hires: Walgreens Appoints New CEO, Cityblock Health, Innovaccer, Others

Executive Hires: Walgreens Appoints New CEO, Cityblock Health, Innovaccer, Others Walgreens appoints Rosalind (Roz) Brewer as the company’s Chief Executive Officer, effective on March 15, 2021. Brewer will also join the WBA Board of Directors upon assuming the role. She succeeds Stefano Pessina who, as previously announced, will transition to the role of Executive Chairman of the Board of WBA. Brewer, 58, will become the first Black woman to lead a Fortune 500 company. Jeff McHugh, former senior Vice President of Sales at R1 RCM, has joined Innovaccer as Regional Vice President of Sales. ...

Conversion Labs Appoints Seasoned Financial and Operational Executive, Marc Benathen, as Chief Financial Officer - Vimarsana News

Conversion Labs Appoints Seasoned Financial and Operational Executive, Marc Benathen, as Chief Financial Officer

Conversion Labs Appoints Seasoned Financial and Operational Executive, Marc Benathen, as Chief Financial Officer February 05, 2021 08:31 ET | Source: Conversion Labs, Inc. Conversion Labs, Inc. NEW YORK, Feb. 05, 2021 (GLOBE NEWSWIRE) -- . (NASDAQ: CVLB), a leading direct-to-consumer telemedicine company, has appointed Marc Benathen as chief financial officer, effective March 1. He succeeds Juan Manuel Piñeiro Dagnery, who will continue as chief revenue officer. Benathen is an accomplished senior financial and operational executive with 18 years of experience lea...

Week Ahead In Pharma: Data Readouts Of COVID-19 Trials & FDA Decisions - Vimarsana News

Week Ahead In Pharma: Data Readouts Of COVID-19 Trials & FDA Decisions

Week Ahead In Pharma: Data Readouts Of COVID-19 Trials & FDA Decisions THOUSAND OAKS (dpa-AFX) - The development and distribution of vaccines have been making headlines amid a surge in COVID-19 cases and this past week was no exception. Novavax Inc. (NVAX), which was up 74%, was one of the top gainers for the week ending January 29, 2021, thanks to encouraging trial results of its COVID-19 vaccine candidate. In a phase III trial, conducted in UK, the two-dose regimen of Novavax vaccine NVX-CoV2373 has been found to have an efficacy rate of 89.3%. Vaxart Inc. (VXRT), with returns of nearly 68...